Companies: 10,639     total market cap: NZ$233.487 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Ascendis Pharma
ASND
#1641
Rank
NZ$21.90 B
Marketcap
๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Country
NZ$358.50
Share price
4.72%
Change (1 day)
45.03%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

EPS for Ascendis Pharma (ASND)

EPS in 2025 (TTM): NZ-$7.46

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is NZ-$7.37. In 2024 the company made an earnings per share (EPS) of NZ-$12.18 an increase over its 2023 EPS that were of NZ-$15.85.

EPS history for Ascendis Pharma from 2023 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.46-38.76%
2024NZ-$12.18-23.17%
2023NZ-$15.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Advaxis
ADXS
NZ-$16.59 125.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
NZ-$8.95 21.47%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Akebia Therapeutics
AKBA
NZ-$0.12-98.37%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com